CD23 | Search

Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

1,304 results for “CD23”

Trials

View all 637 →

Soluble CD23 Expression in Asthma Patients Treated With OMA

80 participants · First posted Sep 26, 2005

Monoclonal Antibody in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma

First posted Apr 9, 2003

Safety and Efficacy of IDEC-152 in the Treatment of Chronic Lymphocytic Leukemia (CLL)

70 participants · First posted Oct 2, 2002

Drugs

View all 615 →

Investigational

Lumiliximab

CD123/CD33-LP-DNR

CD123/CD33 CART(Essen Biotech)

News

View all 52 →

Shanghai Shen Lian's UB-221 Meets Primary Endpoint in Phase II Clinical Trial

CUE-221 Hits Primary and Key Secondary Endpoints in Phase 2 Chronic Spontaneous Urticaria Trial

Treeline and Roche Collaborate on Phase 1 Trial of BCL6 Degrader TLN-121 Combined with CD20×CD3 Bispecifics in B-Cell Lymphomas

Page 1 of 131